Evidence map›Paper›PMID 35190902›Full record

ArticleCellular and molecular life sciences : CMLS2022

MicroRNA-22 promoted osteogenic differentiation of valvular interstitial cells by inhibiting CAB39 expression during aortic valve calcification.

Fan Yang, Suxuan Liu, Ying Gu, Yan Yan, Xueyan Ding, Liangjian Zou, Zhiyun Xu, Guokun Wang

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. The role of microRNAs in calcific aortic valve disease.Frontiers in cardiovascular medicine · 2025
    Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Potential ferroptosis key genes in calcific aortic valve disease.Frontiers in cardiovascular medicine · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Fan Yang *Department of Cardiovascular Surgery, Changhai Hospital, Naval Medical University, 168 Changhai Road, Shanghai, 200433, China.
Suxuan Liu *Department of Cardiology, Changhai Hospital, Naval Medical University, Shanghai, 200433, China.
Ying Gu *Department of Cardiology, Changhai Hospital, Naval Medical University, Shanghai, 200433, China.
Yan YanDepartment of Cardiovascular Surgery, Changhai Hospital, Naval Medical University, 168 Changhai Road, Shanghai, 200433, China.
Xueyan DingDepartment of Cardiology, Changhai Hospital, Naval Medical University, Shanghai, 200433, China.
Liangjian ZouDepartment of Cardiovascular Surgery, Changhai Hospital, Naval Medical University, 168 Changhai Road, Shanghai, 200433, China. dr_zoulj@126.com.
Zhiyun XuDepartment of Cardiovascular Surgery, Changhai Hospital, Naval Medical University, 168 Changhai Road, Shanghai, 200433, China. zhiyunx@hotmail.com.
Guokun WangDepartment of Cardiovascular Surgery, Changhai Hospital, Naval Medical University, 168 Changhai Road, Shanghai, 200433, China. dearwgk@smmu.edu.cn.ORCID http://orcid.org/0000-0002-7394-9968
Second Military Medical University · CN

Funding

national key research and development program of china 2016YFC1100900national natural science foundation of china 81800341national natural science foundation of china 81800342national natural science foundation of china 82000364shanghai science and technology innovation action plan "science and technology support project in biomedical science" 21S11906000
6 · The paper itself

Abstract

Calcific aortic valve disease (CAVD) is a common valve disease characterized by the fibro-calcific remodeling of the aortic valves, which is an actively regulated process involving osteogenic differentiation of valvular interstitial cells (VICs). MicroRNA (miRNA) is an essential regulator in diverse biological processes in cells. The present study aimed to explore the role and mechanism of miR-22 in the osteogenic differentiation of VICs. The expression profile of osteogenesis-related miRNAs was first detected in aortic valve tissue from CAVD patients (n = 33) and healthy controls (n = 12). miR-22 was highly expressed in calcified valve tissues (P < 0.01), and the expression was positively correlated with the expression of OPN (r

Indexed as

Cell DifferentiationOsteogenesisAgedAortic ValveAortic Valve StenosisCalcinosisCalcium-Binding ProteinsCase-Control StudiesFemaleHumansMaleMicroRNAsMiddle AgedCAB39 protein, humanCalcium-Binding ProteinsMicroRNAsMIRN22 microRNA, humanCalcific aortic valve diseaseCalcium-binding protein 39MicroRNAOsteogenic differentiationValvular interstitial cells

Identifiers

PMID35190902
PMCPMC11073073
OpenAlexW4212868139

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.